These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 17656954)

  • 1. Glibenclamide induced photosensitivity.
    Singal A; Bhattacharya SN; Baruah MC
    Indian J Dermatol Venereol Leprol; 2002; 68(4):240-1. PubMed ID: 17656954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.
    Jojima T; Suzuki K; Hirama N; Uchida K; Hattori Y
    Diabetes Obes Metab; 2009 Feb; 11(2):143-9. PubMed ID: 18564176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.
    Sadikot SM; Mogensen CE
    Diabetes Res Clin Pract; 2008 Dec; 82(3):391-5. PubMed ID: 18945509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.
    Ao Y; Chen J; Yue J; Peng RX
    Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbal remedy for diabetes: two case reports.
    Kulambil Padinjakara RN; Ashawesh K; Butt S; Nair R; Patel V
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):3-5. PubMed ID: 19140093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glibenclamide exerts an antitumor activity through reactive oxygen species-c-jun NH2-terminal kinase pathway in human gastric cancer cell line MGC-803.
    Qian X; Li J; Ding J; Wang Z; Duan L; Hu G
    Biochem Pharmacol; 2008 Dec; 76(12):1705-15. PubMed ID: 18840412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual case of extensive xanthogranulomatous orchitis in a diabetic patient.
    Rifat Mannan AA; Kahvic M; Abu Sara Y; Bharati C
    Med Princ Pract; 2009; 18(5):418-21. PubMed ID: 19648768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glibenclamide on acetylcholine and sodium nitroprusside induced vasodilatation in human cutaneous microcirculation.
    Hojs N; Strucl M; Cankar K
    Clin Physiol Funct Imaging; 2009 Jan; 29(1):38-44. PubMed ID: 18823336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of glibenclamide in women with gestational diabetes.
    Holt RI; Clarke P; Parry EC; Coleman MA
    Diabetes Obes Metab; 2008 Sep; 10(10):906-11. PubMed ID: 18093212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia in a healthy toddler.
    Glatstein M; Garcia-Bournissen F; Scolnik D; Koren G; Finkelstein Y
    Ther Drug Monit; 2009 Apr; 31(2):173-7. PubMed ID: 19142176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
    Turkkahraman D; Bircan I; Tribble ND; Akçurin S; Ellard S; Gloyn AL
    J Pediatr; 2008 Jul; 153(1):122-6. PubMed ID: 18571549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
    Slingerland AS; Hurkx W; Noordam K; Flanagan SE; Jukema JW; Meiners LC; Bruining GJ; Hattersley AT; Hadders-Algra M
    Diabet Med; 2008 Mar; 25(3):277-81. PubMed ID: 18307455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroglycopenia and adrenergic responses to hypoglycaemia: insights from a local epidemic of serendipitous massive overdose of glibenclamide.
    Dalan R; Leow MK; George J; Chian KY; Tan A; Han HW; Cheow SP
    Diabet Med; 2009 Jan; 26(1):105-9. PubMed ID: 19125771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruxism possibly induced by venlafaxine.
    Alonso-Navarro H; Martín-Prieto M; Ruiz-Ezquerro JJ; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2009; 32(2):111-2. PubMed ID: 19512964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sulfonylurea glyburide on superoxide dismutase, catalase, and glutathione peroxidase activities in the brain tissue of streptozotocin-induced diabetic rat.
    Nazaroglu NK; Sepici-Dincel A; Altan N
    J Diabetes Complications; 2009; 23(3):209-13. PubMed ID: 18413155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute psychosis following bupropion overdosage].
    Hansen MB; Rasmussen KB; Braendholt V
    Ugeskr Laeger; 2008 Nov; 170(46):3777-8. PubMed ID: 19014730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.